UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies

Journal of the American Heart Association, 2014-04, Vol.3 (2), p.e000665-n/a

2014

Volltextzugriff (PDF)

Late Cardiac Effects of Cancer Treatment

Journal of clinical oncology, 2012-10, Vol.30 (30), p.3657-3664

2012

Volltextzugriff (PDF)

Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?

Journal of clinical oncology, 2008-03, Vol.26 (8), p.1201-1203

2008

Volltextzugriff (PDF)

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis

JACC. Basic to translational science, 2019-06, Vol.4 (3), p.438-448

2019

Volltextzugriff (PDF)

Patterns of Cardiac Toxicity Associated With Irreversible Proteasome Inhibition in the Treatment of Multiple Myeloma

Journal of cardiac failure, 2015-02, Vol.21 (2), p.138-144

2015

Volltextzugriff (PDF)

Validation and Potential Mechanisms of Red Cell Distribution Width as a Prognostic Marker in Heart Failure

Journal of cardiac failure, 2010-03, Vol.16 (3), p.230-238

2010

Volltextzugriff (PDF)

Reversibility of Trastuzumab-Related Cardiotoxicity: New Insights Based on Clinical Course and Response to Medical Treatment

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7820-7826

2005

Volltextzugriff (PDF)

The Utility of Point of Care Biomarkers to Detect Cardiotoxicity during Anthracycline Chemotherapy: A Feasibility Study

Journal of cardiac failure, 2016-06, Vol.22 (6), p.433-438

2016

Volltextzugriff (PDF)

Cardiovascular Toxicity Profiles of Vascular‐Disrupting Agents

The oncologist (Dayton, Ohio), 2011-08, Vol.16 (8), p.1120-1130

2011

Volltextzugriff (PDF)

Loop Diuretic Resistance in Heart Failure: Resistance Etiology–Based Strategies to Restoring Diuretic Efficacy

Journal of cardiac failure, 2014-08, Vol.20 (8), p.611-622

2014

Volltextzugriff (PDF)

Long-Term Cardiac Tolerability of Trastuzumab in Metastatic Breast Cancer: The M.D. Anderson Cancer Center Experience

Journal of clinical oncology, 2006-09, Vol.24 (25), p.4107-4115

2006

Volltextzugriff (PDF)

Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma

British journal of haematology, 2018-01, Vol.180 (2), p.271-275

2018

Volltextzugriff (PDF)

Validation of an Automated Electronic Algorithm and “Dashboard” to Identify and Characterize Decompensated Heart Failure Admissions across a Medical Center

The American heart journal, 2017-01, Vol.183, p.40-48

2017

Volltextzugriff (PDF)

Hypertension in the Cardio-Oncology Clinic

Heart failure clinics, 2019-10, Vol.15 (4), p.487-495

2019

Volltextzugriff (PDF)

Progression of Heart Failure From AHA/ACC Stage A to Stage B or Even C

Journal of the American College of Cardiology, 2012-12, Vol.60 (24), p.2513-2514

Lenihan, Daniel J., MD

2012

Volltextzugriff (PDF)

Echocardiographic and clinical predictors of cardiac amyloidosis: limitations of apical sparing

ESC Heart Failure, 2022-02, Vol.9 (1), p.385-397

2022

Volltextzugriff (PDF)

Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance

Cardio-oncology (London, England), 2023-03, Vol.9 (1), p.14-14, Article 14

2023

Volltextzugriff (PDF)

Cardiac Disease After Breast Cancer Treatment: Make Sure to Check Our Blind Spot

JNCI : Journal of the National Cancer Institute, 2019-08, Vol.111 (8), p.762-763

Lenihan, Daniel J

2019

Volltextzugriff (PDF)

The Compelling Need for a Cardiology and Oncology Partnership and the Birth of the International CardiOncology Society

Progress in cardiovascular diseases, 2010-09, Vol.53 (2), p.88-93

2010

Volltextzugriff (PDF)

Cardiac Biomarkers, Cardiotoxicity, and Active Collaboration

Journal of the American College of Cardiology, 2014-03, Vol.63 (8), p.817-818

Lenihan, Daniel J., MD

2014

Volltextzugriff (PDF)

Peripheral arterial ischemic events in cancer patients

Vascular medicine (London, England), 2011-04, Vol.16 (2), p.119-130

2011

Volltextzugriff (PDF)

Implementing a Machine-Learning-Adapted Algorithm to Identify Possible Transthyretin Amyloid Cardiomyopathy at an Academic Medical Center

Clinical Medicine Insights. Cardiology, 2022-01, Vol.16, p.11795468221133608-11795468221133608

2022

Volltextzugriff (PDF)

Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week

Journal of the American College of Cardiology, 2019-10, Vol.74 (13), p.1714-1727

2019

Volltextzugriff (PDF)

Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial

JACC. Heart failure, 2020-03, Vol.8 (3), p.157-168

2020

Volltextzugriff (PDF)

1 – 25 von 335

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(297)
Mit Volltextzugriff
(303)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(334)
Spanisch
(1)
Polnisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(174)
Life Sciences & Biomedicine
(172)
Humans
(140)
Cardiovascular System & Cardiology
(102)
Cardiac & Cardiovascular Systems
(101)
Female
(65)
Heart Failure
(65)
Male
(65)
Oncology
(59)
Cardiotoxicity
(54)
Cardiovascular
(54)
Biological And Medical Sciences
(47)
Middle Aged
(47)
Medical Sciences
(46)
Aged
(41)
Cardiology
(34)
Cancer
(33)
Cardio-Oncology
(33)
Heart
(32)
Adult
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies

Late Cardiac Effects of Cancer Treatment

Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis

Patterns of Cardiac Toxicity Associated With Irreversible Proteasome Inhibition in the Treatment of Multiple Myeloma

Validation and Potential Mechanisms of Red Cell Distribution Width as a Prognostic Marker in Heart Failure

Reversibility of Trastuzumab-Related Cardiotoxicity: New Insights Based on Clinical Course and Response to Medical Treatment

The Utility of Point of Care Biomarkers to Detect Cardiotoxicity during Anthracycline Chemotherapy: A Feasibility Study

Cardiovascular Toxicity Profiles of Vascular‐Disrupting Agents

Loop Diuretic Resistance in Heart Failure: Resistance Etiology–Based Strategies to Restoring Diuretic Efficacy

Long-Term Cardiac Tolerability of Trastuzumab in Metastatic Breast Cancer: The M.D. Anderson Cancer Center Experience

Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma

Validation of an Automated Electronic Algorithm and “Dashboard” to Identify and Characterize Decompensated Heart Failure Admissions across a Medical Center

Hypertension in the Cardio-Oncology Clinic

Progression of Heart Failure From AHA/ACC Stage A to Stage B or Even C

Echocardiographic and clinical predictors of cardiac amyloidosis: limitations of apical sparing

Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance

Cardiac Disease After Breast Cancer Treatment: Make Sure to Check Our Blind Spot

The Compelling Need for a Cardiology and Oncology Partnership and the Birth of the International CardiOncology Society

Cardiac Biomarkers, Cardiotoxicity, and Active Collaboration

Peripheral arterial ischemic events in cancer patients

Implementing a Machine-Learning-Adapted Algorithm to Identify Possible Transthyretin Amyloid Cardiomyopathy at an Academic Medical Center

Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week

Early Management of Patients With Acute Heart Failure: State of the Art and Future Directions. A Consensus Document From the Society for Academic Emergency Medicine/Heart Failure Society of America Acute Heart Failure Working Group

Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial

Suchergebnisse filtern